# Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia

> **NCT06834490** · PHASE3 · COMPLETED · sponsor: **Pharmasoft** · enrollment: 318 (actual)

## Conditions studied

- Chronic Cerebral Ischemia

## Interventions

- **DRUG:** Mexidol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06834490
- **Lead sponsor:** Pharmasoft
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-05
- **Primary completion:** 2020-12-08
- **Final completion:** 2020-12-08
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06834490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06834490, "Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06834490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*